NASDAQ: VBIVVbi Vaccines Inc Stock Ownership - Who owns Vbi Vaccines?
Insider buying vs selling
Have Vbi Vaccines Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steven Gillis | Director | 2023-07-10 | 609,090 | $1.65 | $1.00MBuy |
VBIV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VBIV insiders and whales buy or sell their stock.
VBIV Shareholders
What type of owners hold Vbi Vaccines Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 145.75% | 41,440,729 | $23.37M | Insider |
| Sam Chawla | 32.96% | 9,370,725 | $5.29M | Insider |
| Opko Health Inc | 21.18% | 6,023,014 | $3.40M | Insider |
| Steven Gillis | 14.32% | 4,072,163 | $2.30M | Insider |
| Tomer Kariv | 13.10% | 3,723,654 | $2.10M | Insider |
| Scott Requadt | 9.60% | 2,728,542 | $1.54M | Insider |
| Ran Nussbaum | 8.07% | 2,295,083 | $1.29M | Insider |
| Perceptive Advisors LLC | 4.86% | 1,381,355 | $779.08k | Institution |
| Alyeska Investment Group LP | 2.20% | 626,436 | $353.31k | Institution |
| Jeff Baxter | 2.14% | 608,255 | $343.06k | Insider |
VBIV vs Biotech Stocks
Vbi Vaccines Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.